The Cooper Companies, Inc.

NasdaqGS:COO Stock Report

Market Cap: US$13.2b

Cooper Companies Future Growth

Future criteria checks 3/6

Cooper Companies is forecast to grow earnings and revenue by 27.8% and 4.8% per annum respectively. EPS is expected to grow by 30.5% per annum. Return on equity is forecast to be 10.5% in 3 years.

Key information

27.8%

Earnings growth rate

30.50%

EPS growth rate

Medical Equipment earnings growth16.2%
Revenue growth rate4.8%
Future return on equity10.47%
Analyst coverage

Good

Last updated08 Jun 2026

Recent future growth updates

Recent updates

Seeking Alpha • Jun 09

Cooper Companies: Demand Growth And Earnings Beat, Needs Stronger ROE And Profit Margins

Summary The Cooper Companies gets a hold rating for my initial coverage. Strengths are driven by the top line and market demand for contact lenses for a variety of eye conditions, with only a handful of key peers in this niche. Margin and ROE improvement remains a challenge, to improve metrics vs peers like Alcon, Bausch & Lomb, and Johson & Johnson, as well as competing on product innovation. COO's operating cashflow growth has shown a positive trend. Read the full article on Seeking Alpha
Narrative Update • Jun 04

COO: Future Returns Will Rely On EPS Strength And Buyback Support

Analysts have nudged their price target for Cooper Companies lower to $87.14 from $91.07 as they factor in modest tweaks to fair value, discount rate, revenue growth, profit margin, and future P/E assumptions. What's in the News Cooper Companies reported Q1 fiscal 2026 revenue that was 8% higher year over year, with non GAAP EPS 20% higher, according to recent earnings coverage.
New Narrative • May 29

Premium Contact Lenses And Fertility Services Will Support Stable But Uneven Future Performance

Catalysts About Cooper Companies Cooper Companies supplies contact lenses through CooperVision and women's health and fertility products and services through CooperSurgical. What are the underlying business or industry changes driving this perspective?
Narrative Update • May 18

COO: Future Returns Will Rely On Steady Buybacks And Earnings Guidance

Analysts have modestly adjusted their price target on Cooper Companies. The updated valuation framework reflects a refreshed discount rate of 8.00%, a stable fair value of $91.07, and a slightly revised future P/E assumption of 25.77x to align more closely with current expectations for the business.
Narrative Update • Apr 25

COO: Future Returns Will Rely On Ongoing Share Repurchases

Analysts have kept their price target for Cooper Companies broadly steady at about $91 per share. This reflects updated assumptions around discount rates, revenue growth, profit margins and future P/E that together point to a similar view of the stock's underlying value.
Narrative Update • Apr 09

COO: Future Returns Will Depend On Ongoing Buybacks And Myopia Management

Analysts have trimmed their price target for Cooper Companies by about $0.73, reflecting slightly updated views on fair value, discount rate, revenue growth, profit margin and future P/E assumptions. What's in the News Cooper Companies reports completing a share repurchase of 1,126,600 shares, or 0.58% of its outstanding stock, for $92.43m between November 1, 2025 and January 31, 2026 under its existing buyback program.
Narrative Update • Mar 26

COO: Future Returns Will Rely On Myopia Management And Persistent Buybacks

Analysts have raised their price target for Cooper Companies slightly, to $91.80 from $91.25, citing updated assumptions around the discount rate, revenue growth, profit margin and future P/E levels. What's in the News Cooper Companies updated its fiscal 2026 earnings guidance, with total revenue projected in a range of $4.306b to $4.346b, described as organic growth of 4.5% to 5.5% (Corporate guidance).
Narrative Update • Mar 12

COO: Future Returns Will Rely On Myopia Management Expansion And Buyback Discipline

Analysts have nudged their price target for Cooper Companies to $91.25 from $91.00, reflecting updated views on fair value, discount rate, revenue growth, profit margin and future P/E assumptions. What's in the News Cooper Companies updated its fiscal 2026 earnings outlook, guiding total revenue to a range of US$4.306b to US$4.346b with organic growth of 4.5% to 5.5% (Corporate guidance).
Narrative Update • Feb 25

COO: Future Returns Will Depend On Myopia Management And Capital Allocation Review

Analysts have maintained their $91.00 price target on Cooper Companies, citing largely unchanged assumptions for revenue growth, profit margin, discount rate, and future P/E. Taken together, these factors indicate a similar view of the stock's long term value compared with prior estimates.
Narrative Update • Feb 09

COO: Future Returns Will Rely On Myopia Management And Capital Review Outcomes

Narrative Update on Cooper Companies Analysts have trimmed their price target on Cooper Companies slightly, now anchoring it around an implied fair value of about $91. This reflects modest adjustments to assumptions about the discount rate, revenue growth, and profit margins.
Narrative Update • Jan 26

COO: Future Returns Will Lean On Myopia Management Expansion Potential

Analysts have nudged their price target for Cooper Companies slightly higher to about $91.06 from roughly $90.88, citing modestly stronger assumptions for revenue growth and profit margins, along with a somewhat lower future P/E multiple. What's in the News CooperVision plans to launch MyDay MiSight 1 day myopia control contact lenses in the UK and select European and surrounding markets, expanding its myopia management portfolio that uses ActivControl Technology and silicone hydrogel material from the MyDay family (Key Developments).
Narrative Update • Jan 09

COO: Future Returns Will Balance Myopia Expansion With Activist Governance Pressure

Analysts have nudged their price target on Cooper Companies slightly higher to US$90.88 from US$90.50, reflecting small model adjustments in fair value estimates, discount rate, revenue growth, profit margin and future P/E assumptions. What's in the News CooperVision plans to launch MyDay MiSight 1 day myopia management contact lenses in the UK and select European and surrounding markets, combining its ActivControl Technology with MyDay silicone hydrogel material to target childhood myopia.
Analysis Article • Jan 06

Is It Too Late To Consider Buying The Cooper Companies, Inc. (NASDAQ:COO)?

The Cooper Companies, Inc. ( NASDAQ:COO ) saw a significant share price rise of 22% in the past couple of months on the...
Narrative Update • Dec 15

COO: Future Returns Will Balance Buybacks With Activist Governance Pressure

Narrative Update on Cooper Companies Analysts have raised their price target on Cooper Companies by 9 percent, from 83 dollars to 90.50 dollars. This reflects increased conviction in the company’s long term earnings power, despite slightly lower growth and margin assumptions, offset by a higher expected valuation multiple.
Narrative Update • Dec 01

COO: Shareholder Value Will Be Driven by Buybacks Amid Leadership Pressure

Analysts have maintained their fair value estimate for Cooper Companies at $83.00, citing only minimal adjustments to growth and profitability assumptions in recent models. What's in the News On November 19, 2025, Browning West LP sent a letter to the Cooper Companies' board criticizing underperformance.
Narrative Update • Nov 17

COO: Expanded Buyback Authorization Will Drive Shareholder Value Higher

Analysts have modestly revised their price target for Cooper Companies to $83.00. They cite slight adjustments in the discount rate and future valuation estimates, reflecting updated market expectations.
Narrative Update • Nov 01

COO: Share Buybacks And Merger Potential Will Drive Undervalued Stock Higher

Analysts have maintained their price target for Cooper Companies at $83.00, citing stability in the company’s fundamental metrics and minimal changes in key financial assumptions. What's in the News Jana Partners LLC has urged Cooper Companies to consider strategic alternatives, including a potential merger of its contact lens unit with Bausch + Lomb Corp, and to improve capital allocation and shareholder returns (Key Developments).
Narrative Update • Oct 17

Global Rollouts And Automation Will Revitalize Contact Lenses

Analysts have slightly lowered their price target for Cooper Companies from $83.19 to $83.00, citing minor adjustments in key financial metrics such as fair value and forward P/E ratio. What's in the News On September 17, 2025, Cooper Companies increased its equity buyback plan by $1,000 million, raising total authorization to $2,000 million (Key Developments).
Narrative Update • Oct 03

Global Rollouts And Automation Will Revitalize Contact Lenses

Analysts have slightly lowered their price target for Cooper Companies from $84.47 to $83.19. They cite minor adjustments in projected revenue growth and profit margins as the reason for this change.
Narrative Update • Aug 29

Expanding MyDay And MiSight Product Lines Will Meet Strong Market Demand

The consensus analyst price target for Cooper Companies has been revised downward, primarily reflecting a reduced future P/E multiple while revenue growth expectations remain stable, resulting in a new price target of $84.56. What's in the News Repurchased 724,300 shares for $52.1 million between May and July 2025; total buyback completed is 5,921,842 shares for $836.4 million (3.03% of shares outstanding).
Analysis Article • Jul 21

Some Investors May Be Worried About Cooper Companies' (NASDAQ:COO) Returns On Capital

Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Firstly, we'd want to...
Analysis Article • Jul 03

Market Participants Recognise The Cooper Companies, Inc.'s (NASDAQ:COO) Earnings

The Cooper Companies, Inc.'s ( NASDAQ:COO ) price-to-earnings (or "P/E") ratio of 35.2x might make it look like a...
Analysis Article • Jun 15

Is It Time To Consider Buying The Cooper Companies, Inc. (NASDAQ:COO)?

Today we're going to take a look at the well-established The Cooper Companies, Inc. ( NASDAQ:COO ). The company's stock...
Seeking Alpha • Mar 01

CooperCompanies: A Somewhat Less Demanding Valuation, But Some Added Growth Concerns

Summary CooperCompanies' Vision business has faced some recent concerns about growth, but long-term growth opportunities in toric lenses, dailies, myopia management, and fertility remain strong. Vision sales have been impacted by distributor inventory management and possibly a softer overall U.S. market, but growth should be bottoming and can reaccelerate on share growth across the business. The Fertility business is leveraged by a worldwide trend toward having children later in life, a growing global middle class, and governments improving fertility treatment reimbursement to encourage population growth. Despite strong EBITDA margins, Cooper has underwhelmed with free cash flow generation, but management is focused on improving this over the coming years. The stock's recent 20% pullback presents a potential buying opportunity, though some investors may want to wait for FQ1'25 results and guidance before stepping up. Read the full article on Seeking Alpha
Seeking Alpha • Oct 09

The Cooper Companies: Winning Share In Contact Lens Markets

Summary I reiterate a ‘Buy’ rating for Cooper with a fair value of $120 per share due to their strong market share gains and strategic acquisitions. CooperVision's revenue grew 10% organically, driven by their focus on Torics, Multifocal, and daily disposable contact lenses, outpacing the market's 7% growth. Recent acquisitions of obp Surgica and ZyMōt Fertility align with Cooper’s M&A strategy, enhancing their technology in vision and fertility markets. Cooper’s pricing power and cost optimization efforts are expected to drive margin expansion, with projected total revenue growth of 9.5% annually. Read the full article on Seeking Alpha
User avatar
New Narrative • Aug 29

Innovative Growth In Myopia Management And Fertility Boosts Future Prospects

Expansion in manufacturing and new product introductions alongside strategic R&D investments in myopia and fertility are driving growth and margins.
Seeking Alpha • Aug 26

The Cooper Companies: Still An Expensive Place

Summary The Cooper Companies continues to pursue M&A to grow its CooperSurgical business. Over time, the company is finding a greater balance between this business and its core CooperVision segment. Cooper shares have been trading range bound for a long period of time, as shares are growing into a very premium valuation. Read the full article on Seeking Alpha
Seeking Alpha • Jun 14

Cooper Companies: Business Growth Noted, Valuations An Ask

Summary The healthcare sector offers average value compared to the S&P 500 on a price-value basis. Cooper Companies, Inc. presents with robust business fundamentals but investors are pricing the company to perfection. Q1 FY 2024 earnings show strong growth, but the stock appears stretched at 26x forward earnings in my view. Read the full article on Seeking Alpha
Seeking Alpha • Mar 22

The Cooper Companies: Rating Upgrade As Near-Term Momentum Should Continue

Summary The Cooper Companies stock saw a sharp reversion in share price, leading to a buy rating with an expected 8% return over 6 months. COO's recent results showed 8% growth in constant currency, beating revenue estimates, and raising guidance for FY24. COO is well-positioned to continue delivering growth above the market, with strong product fit and distribution capabilities, and potential for expansion in the myopia management segment. Read the full article on Seeking Alpha

Earnings and Revenue Growth Forecasts

NasdaqGS:COO - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
10/31/20284,7557969161,20511
10/31/20274,5176607901,05416
10/31/20264,30841558383515
4/30/20264,231236570953N/A
1/31/20264,152401491866N/A
10/31/20254,092375434796N/A
7/31/20254,046408412816N/A
4/30/20253,988414366762N/A
1/31/20253,929415385777N/A
10/31/20243,895392288709N/A
7/31/20243,804359189615N/A
4/30/20243,732340122550N/A
1/31/20243,666291136564N/A
10/31/20233,593294215608N/A
7/31/20233,514275222564N/A
4/30/20233,427288387685N/A
1/31/20233,380375425693N/A
10/31/20223,308386450692N/A
7/31/20223,219431524736N/A
4/30/20223,139948487696N/A
1/31/20223,029939541757N/A
10/31/20212,9232,945524739N/A
7/31/20212,8452,916526782N/A
4/30/20212,6602,355414671N/A
1/31/20212,4652,249207505N/A
10/31/20202,431238176487N/A
7/31/20202,441278180468N/A
4/30/20202,542343234552N/A
1/31/20202,672454N/A741N/A
10/31/20192,653467N/A713N/A
7/31/20192,613446N/A750N/A
4/30/20192,594427N/A788N/A
1/31/20192,571366N/A745N/A
10/31/20182,533140N/A669N/A
7/31/20182,443128N/A631N/A
4/30/20182,339131N/A551N/A
1/31/20182,230175N/A511N/A
10/31/20172,139373N/A594N/A
7/31/20172,096345N/A588N/A
4/30/20172,055329N/A562N/A
1/31/20172,016298N/A529N/A
10/31/20161,967274N/A510N/A
7/31/20161,904250N/A421N/A
4/30/20161,851207N/A388N/A
1/31/20161,801194N/A401N/A
10/31/20151,797204N/A391N/A
7/31/20151,810198N/A439N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: COO's forecast earnings growth (27.8% per year) is above the savings rate (3.5%).

Earnings vs Market: COO's earnings (27.8% per year) are forecast to grow faster than the US market (17.9% per year).

High Growth Earnings: COO's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: COO's revenue (4.8% per year) is forecast to grow slower than the US market (12.5% per year).

High Growth Revenue: COO's revenue (4.8% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: COO's Return on Equity is forecast to be low in 3 years time (10.5%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/11 21:32
End of Day Share Price 2026/06/11 00:00
Earnings2026/04/30
Annual Earnings2025/10/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

The Cooper Companies, Inc. is covered by 27 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jeffrey JohnsonBaird
Matthew MiksicBarclays
Joanne WuenschBMO Capital Markets Equity Research